Search Results

There are 39146 results for: content related to: Faldaprevir combined with peginterferon alfa-2a and ribavirin in chronic hepatitis C virus genotype-1 patients with prior nonresponse: SILEN-C2 trial

  1. You have free access to this content
    Faldaprevir combined with pegylated interferon alfa-2a and ribavirin in treatment-naïve patients with chronic genotype1 HCV: SILEN-C1 trial

    Hepatology

    Volume 57, Issue 6, June 2013, Pages: 2143–2154, Mark S. Sulkowski, Tarik Asselah, Jacob Lalezari, Peter Ferenci, Hugo Fainboim, Barbara Leggett, Fernando Bessone, Stefan Mauss, Jeong Heo, Yakov Datsenko, Jerry O. Stern, George Kukolj, Joseph Scherer, Gerhard Nehmiz, Gerhard G. Steinmann and Wulf O. Böcher

    Version of Record online : 12 JUN 2013, DOI: 10.1002/hep.26276

  2. Safety and efficacy of faldaprevir with pegylated interferon alfa-2a and ribavirin in Japanese patients with chronic genotype-1 hepatitis C infection

    Liver International

    Volume 34, Issue 1, January 2014, Pages: 78–88, Shuhei Nishiguchi, Yoshiyuki Sakai, Makoto Kuboki, Satoshi Tsunematsu, Yasuhisa Urano, Wataru Sakamoto, Yasuhiro Tsuda, Gerhard Steinmann and Masao Omata

    Version of Record online : 15 AUG 2013, DOI: 10.1111/liv.12254

  3. Treating hepatitis C: current standard of care and emerging direct-acting antiviral agents

    Journal of Viral Hepatitis

    Volume 19, Issue 7, July 2012, Pages: 449–464, F. Poordad and D. Dieterich

    Version of Record online : 7 JUN 2012, DOI: 10.1111/j.1365-2893.2012.01617.x

  4. You have free access to this content
    Viral Hepatitis

    Journal of Gastroenterology and Hepatology

    Volume 28, Issue S2, October 2013, Pages: 151–177,

    Version of Record online : 10 SEP 2013, DOI: 10.1111/jgh.12365_14

  5. You have free access to this content
    Alisporivir plus ribavirin, interferon free or in combination with pegylated interferon, for hepatitis C virus genotype 2 or 3 infection

    Hepatology

    Volume 62, Issue 4, October 2015, Pages: 1013–1023, Jean-Michel Pawlotsky, Robert Flisiak, Shiv K. Sarin, Jens Rasenack, Teerha Piratvisuth, Wan-Long Chuang, Cheng-Yuan Peng, Graham R. Foster, Samir Shah, Heiner Wedemeyer, Christophe Hézode, Wei Zhang, Kelly A. Wong, Bin Li, Claudio Avila, Nikolai V. Naoumov and on behalf of the VITAL-1 study team

    Version of Record online : 10 AUG 2015, DOI: 10.1002/hep.27960

  6. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Version of Record online : 1 OCT 2012, DOI: 10.1002/hep.26040

  7. You have free access to this content
    HCV Therapeutics: New Agents

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 730A–760A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26858

  8. You have free access to this content
    Safety and efficacy of faldaprevir in combination with pegylated interferon α-2b and ribavirin in Japanese patients with genotype-1 chronic hepatitis C virus infection

    Hepatology Research

    Volume 47, Issue 3, March 2017, Pages: E142–E151, Shuhei Nishiguchi, Yasuhisa Urano, Keiko Suzaki, Atsushi Taniguchi, Joseph Scherer, Kristi L. Berger, Anne-Marie Quinson, Jerry O. Stern and Masao Omata

    Version of Record online : 10 AUG 2016, DOI: 10.1111/hepr.12741

  9. You have free access to this content
    Poster Session IV (Abstracts 1638 – 2112)

    Hepatology

    Volume 64, Issue S1, October 2016, Pages: 811–1050,

    Version of Record online : 1 OCT 2016, DOI: 10.1002/hep.28800

  10. You have free access to this content
    Vaniprevir with pegylated interferon alpha-2a and ribavirin in treatment-naïve patients with chronic hepatitis C: A randomized phase II study

    Hepatology

    Volume 56, Issue 3, September 2012, Pages: 884–893, Michael P. Manns, Edward Gane, Maribel Rodriguez-Torres, Albrecht Stoehr, Chau-Ting Yeh, Patrick Marcellin, Richard T. Wiedmann, Peggy M. Hwang, Luzelena Caro, Richard J.O. Barnard, Andrew W. Lee and for the MK-7009 Protocol 007 Study Group

    Version of Record online : 17 JUL 2012, DOI: 10.1002/hep.25743

  11. You have free access to this content
    HCV Therapy: The Developmental Pipeline

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 429A–447A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26845

  12. You have free access to this content
    Poster Session 2: Hepatitis C: Therapeutics (Approved Agents)

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 714A–807A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28228

  13. Interactions of the hepatitis C virus protease inhibitor faldaprevir with cytochrome P450 enzymes: In vitro and in vivo correlation

    The Journal of Clinical Pharmacology

    Volume 55, Issue 4, April 2015, Pages: 467–477, John P. Sabo, Jens Kort, Charles Ballow, Angela D.M. Kashuba, Manuel Haschke, Manuel Battegay, Birgit Girlich, Naitee Ting, Benjamin Lang, Wei Zhang, Curtis Cooper, Drané O'Brien, Eleanore Seibert, Tom S. Chan, Donald Tweedie and Yongmei Li

    Version of Record online : 14 JAN 2015, DOI: 10.1002/jcph.436

  14. You have full text access to this OnlineOpen article
    International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

    Journal of the International AIDS Society

    Volume 19, Issue 8S7, October 2016,

    Version of Record online : 23 OCT 2016, DOI: 10.7448/IAS.19.8.21487

  15. You have free access to this content
    Posters (Abstracts 264–2239)

    Hepatology

    Volume 66, Issue S1, October 2017, Pages: 149–1185,

    Version of Record online : 1 OCT 2017, DOI: 10.1002/hep.29501

  16. You have full text access to this OnlineOpen article
    Expert opinion on the treatment of patients with chronic hepatitis C

    Journal of Viral Hepatitis

    Volume 16, Issue 2, February 2009, Pages: 75–90, S. Zeuzem, T. Berg, B. Moeller, H. Hinrichsen, S. Mauss, H. Wedemeyer, C. Sarrazin, D. Hueppe, E. Zehnter and M. P. Manns

    Version of Record online : 28 AUG 2008, DOI: 10.1111/j.1365-2893.2008.01012.x

  17. You have free access to this content
    Poster Session 4: Hepatitis C: New Agents (Not Approved)

    Hepatology

    Volume 60, Issue S1, October 2014, Pages: 1128A–1161A,

    Version of Record online : 1 OCT 2014, DOI: 10.1002/hep.27533

  18. Novel Therapeutic Approaches for Hepatitis C

    Clinical Pharmacology & Therapeutics

    Volume 95, Issue 1, January 2014, Pages: 78–88, JS Au and PJ Pockros

    Version of Record online : 19 DEC 2013, DOI: 10.1038/clpt.2013.206

  19. Direct-acting antivirals for chronic hepatitis C

    Intervention Review

    The Cochrane Library

    Janus C Jakobsen, Emil Eik Nielsen, Joshua Feinberg, Kiran Kumar Katakam, Kristina Fobian, Goran Hauser, Goran Poropat, Snezana Djurisic, Karl Heinz Weiss, Milica Bjelakovic, Goran Bjelakovic, Sarah Louise Klingenberg, Jian Ping Liu, Dimitrinka Nikolova, Ronald L Koretz and Christian Gluud

    Published Online : 18 SEP 2017, DOI: 10.1002/14651858.CD012143.pub3

  20. Hepatitis C therapy in non-genotype 1 patients: the near future

    Journal of Viral Hepatitis

    Volume 19, Issue 8, August 2012, Pages: 525–536, C. Wartelle-Bladou, G. Le Folgoc, M. Bourlière and L. Lecomte

    Version of Record online : 4 JUL 2012, DOI: 10.1111/j.1365-2893.2012.01634.x